Editorial Note: This article is written with editorial review and topic relevance in mind.
The end of the trial now means the company can push for an emergency u.s. Pfizer's vaccine trial has finished with a 95% success rate.
Obituary Guestbook Mary Lamothe of Tiverton, Rhode Island Silva